$194 Million is the total value of Birchview Capital, LP's 0 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 63.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | Sell | CELGENE CORP | $110,976,000 | +10.3% | 761,051 | -1.8% | 57.32% | +7.7% |
| SITOQ | Sell | SITO MOBILE LTD | $857,000 | +65.1% | 120,000 | -14.3% | 0.44% | +61.1% |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $412,000 | -37.1% | 5,000 | -28.6% | 0.21% | -38.6% |
| QTNT | Sell | QUOTIENT LTD | $294,000 | -49.9% | 59,700 | -25.1% | 0.15% | -51.1% |
| MACK | Exit | MERRIMACK PHARMACEUTICALS INC | $0 | – | -44,000 | -100.0% | -0.03% | – |
| PACB | Exit | PACIFIC BIOSCIENCES OF CALIFORNIA INC | $0 | – | -27,000 | -100.0% | -0.05% | – |
| ROKA | Exit | ROKA BIOSCIENCE INC | $0 | – | -46,731 | -100.0% | -0.06% | – |
| OPK | Exit | OPKO HEALTH INC | $0 | – | -24,158 | -100.0% | -0.08% | – |
| ADXS | Exit | ADVAXIS INC | $0 | – | -35,600 | -100.0% | -0.12% | – |
| PRTK | Exit | PARATEK PHARMACEUTICALS INC | $0 | – | -30,150 | -100.0% | -0.38% | – |
| NXTM | Exit | NXSTAGE MEDICAL INC | $0 | – | -34,200 | -100.0% | -0.45% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-02
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACCELERATE DIAGNOSTICS INC | 36 | Q3 2023 | 34.6% |
| QUIDELORTHO CORP | 36 | Q3 2023 | 8.6% |
| MASIMO CORP | 36 | Q3 2023 | 2.2% |
| PIONEER NATURAL RESOURCES CO (PXD) | 36 | Q3 2023 | 0.7% |
| XENCOR INC | 35 | Q3 2023 | 0.4% |
| NEUROCRINE BIOSCIENCES INC | 33 | Q3 2023 | 7.4% |
| CORCEPT THERAPEUTICS INC | 32 | Q3 2023 | 1.2% |
| BIOGEN INC | 31 | Q2 2022 | 3.1% |
| CONTRAFECT CORP | 30 | Q3 2022 | 1.6% |
| YIELD10 BIOSCIENCE INC | 26 | Q3 2023 | 0.6% |
View Birchview Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SOLENO THERAPEUTICS INC | March 19, 2019 | 742,635 | 2.3% |
| YIELD10 BIOSCIENCE, INC. | December 29, 2017 | 186,079 | 2.2% |
| HANSEN MEDICAL INC | February 16, 2016 | ? | ? |
| METABOLIX, INC. | June 23, 2015 | 749,696 | 2.8% |
View Birchview Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 3/A | 2024-02-20 |
| 4/A | 2024-02-20 |
| SC 13G/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-04-07 |
| 4 | 2023-03-27 |
View Birchview Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.